BMY · ISSUER CIK 14272
BRISTOL MYERS SQUIBB CO
Between Aug 1, 2026 and Oct 29, 2026, 4 BRISTOL MYERS SQUIBB CO insiders reported $0.00 of open-market purchases and $437K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$437KInsider selling
−$437KNet open-market
Oct 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:18 | Oct 2, 2026 | BMY | EVP, General Counsel | M · Exercise | — | +4,559 | 18,208 | +33% | — | ||
| Oct 5, 202616:18 | Oct 2, 2026 | BMY | EVP, General Counsel | F · Tax | $61.15 | −2,332 | 15,876 | -13% | $143K | ||
| Sep 10, 202616:37 | Sep 9, 2026 | BMY | EVP,Chief Med Offr,Head of Dev | S · Sell | $64.57 | −6,249 | 18,748 | -25% | −$403K | ||
| Sep 3, 202616:12 | Sep 1, 2026 | BMY | EVP, Corporate Affairs | M · Exercise | $66.92 | +1,236 | 13,317 | +10% | $83K | ||
| Sep 3, 202616:12 | Sep 1, 2026 | BMY | EVP, Corporate Affairs | F · Tax | $66.92 | −633 | 12,684 | -5% | $42K | ||
| Aug 26, 202616:17 | Aug 25, 2026 | BMY | SVP and Controller | S · Sell | $67.50 | −500 | 16,862 | -3% | −$34K | ||
| Aug 4, 202616:10 | Aug 1, 2026 | BMY | EVP,Chief Med Offr,Head of Dev | M · Exercise | — | +51,172 | 51,172 | New | — | ||
| Aug 4, 202616:10 | Aug 1, 2026 | BMY | EVP,Chief Med Offr,Head of Dev | F · Tax | $65.31 | −26,175 | 24,997 | -51% | $1.7M | ||
| Aug 4, 202616:07 | Aug 1, 2026 | BMY | EVP, General Counsel | M · Exercise | — | +1,061 | 14,192 | +8% | — | ||
| Aug 4, 202616:07 | Aug 1, 2026 | BMY | EVP, General Counsel | F · Tax | $65.31 | −543 | 13,649 | -4% | $35K |